Dr. Mary-Ellen Taplin of @danafarber.bsky.social shares with People Magazine how her personal experience as a patient and caretaker has shaped her commitment to advancing care for patients with #ProstateCancer and advancing research into new treatment approaches. ➡️ bit.ly/3SfSwN8
In People magazine: From his hospital bed, Robbie Fox and Kelli Peters, both 27, said “I do” just 10 days before he succumbed to Ewing sarcoma. The couple got engaged in March 2025, after Fox went into remission following treatment at @danafarber.bsky.social. ➡️bit.ly/4uUTwoz
Congratulations to @danafarber.bsky.social’s Ann Partridge, MD, MPH, who is the recipient of @gohealio.bsky.social’s 2026 Lifetime Disruptor Award in recognition of her outstanding and ongoing contributions to the field of breast cancer research and treatment.
“We’ve demonstrated that we can successfully run trials for adolescents & young adults with sarcomas, and we're excited to have a growing portfolio of drugs and clinical trials for these diseases,” says @danafarber.bsky.social’s Dr. David Shulman. @dfciayasarcoma.bsky.social ➡️bit.ly/3RWIq3O
Pancreatic Cancer Screening: @danafarber.bsky.social's Dr. Asaf Maoz discusses potential blood-based biomarkers with @ascopost.bsky.social. ➡️bit.ly/4enYymn
Dr. Hal Burstein of @danafarber.bsky.social spoke with @nbcnews.com about male breast cancer following Tyler Mane’s announcement that he has been diagnosed with this rare but highly treatable disease. ➡️bit.ly/4eEv5pt
Dana-Farber research supports FDA approval of pembrolizumab-belzutifan combination for higher-risk clear cell kidney cancer after surgery. Research led by @drchoueiri.bsky.social of @danafarber.bsky.social.
Read more here: bit.ly/447yerK
Marilyn Hammer, PhD, DC, RN, FAAN, director of @danafarber.bsky.social’s Cantor Center for Research, tells Oncology Nursing News how its mission over 25 yrs expanded to precision health symptom science & health equity while bridging the gap between academic research/clinical bedside. bit.ly/4vN5656
New research by @danafarber.bsky.social’s Dr. Suzanne George in JNCI Cancer Spectrum describes the user-centered development and pilot implementation of the Participant Engagement Portal (PEP) by @alliance-org.bsky.social to improve information flow. Read more: bit.ly/43w3Res
Featured in @bostonglobe.com: From his hospital bed, college sweethearts Robbie Fox and Kelli Peters, both 27, married just 10 days before his death from a rare, aggressive bone cancer. The couple got engaged after Fox went into remission following treatment at @danafarber.bsky.social bit.ly/4gpmB6U
Robbie Fox and Kelli Peters married in a hospital ceremony on April 15, just 10 days before his death following an Ewing Sarcoma diagnosis.
Published: June 8, 2026Sarcomas are cancers that occur in bone or soft tissue, such as muscles and fat. These cancers are rare and diverse, with more than 150 different variations. Treatment is advancing for some sarcomas, but most forms of the disease are still treated using chemotherapy, radiation and/or surgery. In some cases, there are few options if the cancer comes back. Dana-Farber physician-scientists are evaluating innovative ... Read more
Talk of breast cancer is often “shrouded in pink,” one expert said, which can lead to less awareness among men about potential risk factors and symptoms.
AbstractBackground. Digital tools may enhance clinical trial engagement by improving information flow and supporting participant-directed communication. Th
A woman was diagnosed with breast cancer amid her late husband's struggles with a fatal brain tumor. The joint health issues inspired Mary-Ellen Taplin's oncology work, she tells PEOPLE exclusively.
ASCO 2026 ssessment of CA 19-9 has utility as part of pancreatic cancer surveillance among high-risk individuals ( Asaf Maoz, MD , of Dana-Farber Cancer Institute, Mass General Brigham, and Harvard Medical School, talks about whether prospective a Abstract 10527).
